Panbela Therapeutics Inc. (PBLA)
OTC: PBLA
· Real-Time Price · USD
0.32
0.00 (0.00%)
At close: Apr 04, 2025, 3:56 PM
0.00% (1D)
| Bid | 0.32 |
| Market Cap | 1.55M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -34.51 |
| PE Ratio (ttm) | -0.01 |
| Forward PE | -0.07 |
| Analyst | Hold |
| Ask | 0.34 |
| Volume | 2,000 |
| Avg. Volume (20D) | 20,924 |
| Open | 0.32 |
| Previous Close | 0.32 |
| Day's Range | 0.32 - 0.32 |
| 52-Week Range | 0.30 - 1.11 |
| Beta | 1.25 |
About PBLA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PBLA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PBLA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
6 months ago · seekingalpha.com
Panbela Therapeutics, Inc. (PBLA) Q3 2024 Earnings Call TranscriptPanbela Therapeutics, Inc. (OTCQB:PBLA) Q3 2024 Earnings Conference Call November 14, 2024 4:30 PM ET Company Participants Jennifer Simpson - CEO Sue Horvath - CFO Conference Call Participants Jonatha...